United BioSource LLC (UBC), founded in 2004 and based in the United States, operates within the Business Services industry, specifically focusing on research and development, corporate services, and education related to biotech and pharmaceuticals. The company employs between 1,001 and 5,000 individuals and reported a revenue of approximately $380 million. UBC's published documents highlight its expertise in pharmacovigilance (PV) and patient engagement strategies, particularly in managing safety signals and compliance with regulatory requirements for pharmaceutical products. For instance, one case study illustrates UBC's role as a Functional Service Provider (FSP) for a pharmaceutical client, where it managed signal detection and risk management for a portfolio of neuro-rheumo/immuno products. Another case study emphasizes UBC's efforts in supporting sickle cell disease patients through personalized clinical services aimed at enhancing medication adherence and patient satisfaction. Additionally, UBC has produced guides and white papers on lessons learned in risk evaluation and management, underscoring its commitment to improving patient safety and healthcare outcomes.